Fennec Pharmaceuticals FENC
NASDAQ FENC
$10.54 +0.08 (+0.76%)
As of: Oct 21, 2026 · 11:39 AM EDT

Fennec Pharmaceuticals (FENC) Current Deferred Revenue (2024 - 2026)

Updated

Fennec Pharmaceuticals' Current Deferred Revenue came in at $3.18 million for Q2 2026, compared with $248,000 a year earlier.

Analysis

Fennec Pharmaceuticals (FENC) Current Deferred Revenue (2024 - 2026) Analysis & Trends

At the end of FY2025, Fennec Pharmaceuticals' Current Deferred Revenue was $248,000, unchanged from FY2024.

  • Going back by year, Current Deferred Revenue was $248,000 in FY2024.
  • The Q2 2026 figure represents the highest quarterly Current Deferred Revenue in data going back to Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 Fennec Pharmaceuticals 362.55 Mn 243.86 Mn 17.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.18 Mn
Dec 31, 2025 248,000.00
Sep 30, 2025 248,000.00
Jun 30, 2025 248,000.00
Mar 31, 2025 248,000.00
Dec 31, 2024 248,000.00
Sep 30, 2024 248,000.00
Jun 30, 2024 252,000.00
Mar 31, 2024 252,000.00
API Access

Fennec Pharmaceuticals Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=FENC&period=max&api_key=YOUR_API_KEY